S. Cuevas Ocaña (Nottingham, United Kingdom)
Predictive factors of vitamin D status in southern-mediterranean patients with COPD
M. Chaabouni (Sfax, Tunisia), W. Feki (Sfax, Tunisia), K. Chaabouni (Sfax, Tunisia), K. Abdelmouleh (Sfax, Tunisia), Y. Elloumi (Sfax, Tunisia), N. Moussa (Sfax, Tunisia), S. Msaad (Sfax, Tunisia), F. Makni Ayadi (Sfax, Tunisia), S. Kammoun (Sfax, Tunisia)
|   |
Monitoring COPD patients according to the GOLD 2017 document: systemic and bronchial inflammation.
P. Pignatti (Pavia, Italy), D. Visca (Tradate (VA), Italy), F. Cherubino (Tradate (VA), Italy), M. Zappa (Tradate (VA), Italy), L. Saderi (Sassari, Italy), E. Zampogna (Tradate (VA), Italy), G. Sotgiu (Sassari, Italy), A. Spanevello (Tradate (VA), Italy)
| |
Exploring respiratory rate as a novel health marker in COPD
G. France (Leicester, United Kingdom), N. Greening (Leicester, United Kingdom), D. Eslinger (Loughborough, United Kingdom), M. Steiner (Leicester, United Kingdom), S. Singh (Leicester, United Kingdom), M. Orme (Leicester, United Kingdom)
| |
Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease
K. Tot Vereš (Novi Sad, Republic of Serbia), M. Ilic (Novi Sad, Republic of Serbia), B. Zvezdin (Novi Sad, Republic of Serbia), N. Savic (Novi Sad, Republic of Serbia), A. Milenkovic Jakic (Novi Sad, Republic of Serbia)
| |
Features of differences in clinical anamnestic, functional indicators, and alpha-1-antitripsin, in teenagers with chronic bronchitis, in the gender-age aspect
N. Mokina (Samara (Samara region), Russian Federation), V. Pyatin (Samara (Samara region), Russian Federation), E. Mokin (Samara (Samara region), Russian Federation)
| |
Different clinical suspect that brings to the diagnosis of alpha1-antitrypsin deficiency
S. Ottaviani (Pavia (PV), Italy), B. Balbi (Veruno (NO), Italy), V. Barzon (Pavia (PV), Italy), A. Balderacchi (Pavia (PV), Italy), A. Corino (Pavia (PV), Italy), D. Piloni (Pavia (PV), Italy), F. Mariani (Pavia (PV), Italy), A. Corsico (Pavia (PV), Italy), I. Ferrarotti (Pavia (PV), Italy)
| |
Comparison between tools for measuring breathlessness: cross-sectional observation and predictive properties
M. Kusunose (Obu, Aichi, Japan), R. Sanda (Obu, Aichi, Japan), A. Narita (Obu, Aichi, Japan), K. Nishimura (Obu, Aichi, Japan)
| |
Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit
X. Chen (Melbourne, Australia), N. Smallwood (Melbourne, Australia)
| |
Using pharmacy sales data to estimate treated COPD prevalence in Portugal
A. T. Rodrigues (Lisboa, Portugal), M. Romão (Lisboa, Portugal), R. Pereira (Lisboa, Portugal), H. Peter (Lisboa, Portugal), A. Marques (Lisboa, Portugal), L. Rocha (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal), J. Alves (Lisboa, Portugal)
| |
Differences in health related quality of life among caregivers of COPD patients according to the level of perceived burden
A. Martínez (Ciudad de México, Mexico), V. Peláez Hernández (Ciudad de México, Mexico), D. Gonzales Islas (Ciudad de México, Mexico), A. Orea Tejeda (Ciudad de México, Mexico), K. Santillán Reyes (Ciudad de México, Mexico), K. Rosales Castillo (Ciudad de México, Mexico), G. Luna Rodríguez (Ciudad de México, Mexico), V. Martínez Vázquez (Ciudad de México, Mexico), M. Gómez Martínez (Ciudad de México, Mexico)
| |
Sex differences in chronic respiratory failure patients users of long-term oxygen therapy
N. Guediri (Tunia, Tunisia), J. Ben Amar (Tunia, Tunisia), H. Zaibi (Tunia, Tunisia), B. Dhahri (Tunia, Tunisia), H. Aouina (Tunia, Tunisia)
| |
Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease
J. Shaikh (Karachi, Pakistan), N. Ahmed Rao (Karachi, Pakistan)
| |
PROMS and FEV1 as predictors of AECOPD
G. Drivas (Athens, Greece), G. Hillas (Athens, Greece), A. Papaporfyriou (Athens, Greece), M. Kaponi (Athens, Greece), K. Dimakou (Athens, Greece)
| |
Does smoking affect nutritional status and renal function in patients with COPD?
O. Boiko (Dnipro, Ukraine), V. Rodionova (Dnipro, Ukraine)
| |
Stratifying COPD patients by cluster analysis using clinical and behavioral variables
C. van Zelst (Rotterdam, Netherlands), L. Goossens (Rotterdam, Netherlands), M. Rutten- Van Molken (Rotterdam, Netherlands), J. In 'T Veen (Rotterdam, Netherlands)
| |
Atherosclerosis of the bracheocephalic arteries in healthy smokers and patients with COPD
V. Nevzorova (Vladivostok (Primorsky Krai), Russian Federation), E. Kondrashova (Vladivostok (Primorsky Krai), Russian Federation), D. Bogdanov (Vladivostok (Primorsky Krai), Russian Federation), T. Khairzamanova (Vladivostok (Primorsky Krai), Russian Federation)
| |
Is anemia associated with readmission risk in severe acute exacerbation of COPD: Preliminary results from a naturalistic cohort
S. Özuygur (Izmir, Turkey), A. Ozgen Alpaydin (Izmir, Turkey), S. Ercan (Izmir, Turkey), C. Sahan (Izmir, Turkey), K. Tertemiz (Izmir, Turkey)
| |
Comparison of prognostic significance of the quality of life questionnaires in patients with COPD combined with hypertension
A. Melenevych (Kharkiv, Ukraine)
| |
Lung function differences between men and women with COPD
R. Barros (Lisboa, Portugal), C. Santos (Lisboa, Portugal), T. Pereira (Lisboa, Portugal), A. Oliveira (Lisboa, Portugal), C. Bárbara (Lisboa, Portugal)
| |
Prevalence,determinants and impact of nocturnal hypoxemia in COPD patients not candidates for domiciliary oxygen therapy
t. sarkar (mumbai, India), L. Pinto (mumbai, India), A. Mahashur (mumbai, India)
| |